杏昌

0.00 (0.00%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

128.0014成交張數14.55本益比1.93股價淨值比5.47%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	53	30	44.2%	1.56	66.31	13.5%	7.6%	1.1	0.9
2026Q1	53	32	40.1%	1.78	70.89	12.4%	7.6%	-0.3	-0.5
2025Q4	51	31	40.0%	1.72	68.53	12.2%	7.3%	1.6	1.3
2025Q3	50	30	40.7%	1.70	66.51	11.8%	7.0%	1.1	0.8
2025Q2	50	29	43.1%	1.57	64.33	11.7%	6.7%	1.5	1.1
2025Q1	50	31	38.4%	1.83	69.34	11.3%	7.1%	-0.2	-0.4
2024Q4	50	30	39.5%	1.77	67.43	12.0%	7.5%	2.3	2.2
2024Q3	49	30	40.1%	1.75	66.30	12.6%	7.8%	1.5	-0.5
2024Q2	50	29	42.5%	1.63	64.68	13.2%	7.9%	1.8	1.5
2024Q1	48	31	35.8%	2.18	69.21	11.8%	7.4%	-0.5	-0.5
2023Q4	46	30	35.4%	2.23	67.02	12.8%	7.6%	1.9	1.7
2023Q3	46	29	36.3%	2.15	65.26	13.4%	7.8%	1.2	1.2
2023Q2	45	28	37.8%	2.00	63.26	13.0%	7.2%	1.3	1.2
2023Q1	49	30	39.1%	2.00	73.42	13.3%	7.8%	-0.1	-0.2
2022Q4	45	24	45.9%	1.58	60.20	15.4%	8.2%	2.2	2.1
2022Q3	45	23	47.9%	1.49	57.94	16.3%	8.4%	0.2	-0.1
2022Q2	46	23	50.3%	1.42	56.26	17.0%	8.7%	1.6	1.5
2022Q1	43	24	43.5%	1.68	60.20	15.6%	8.4%	0.0	-0.5
2021Q4	44	23	48.1%	1.53	57.56	16.2%	8.1%	2.9	2.6
2021Q3	43	22	48.9%	1.48	55.44	16.5%	8.0%	-0.4	-0.9
2021Q2	44	23	47.4%	1.56	59.12	17.3%	8.5%	0.6	0.1
2021Q1	42	22	49.2%	1.72	56.31	16.7%	8.4%	-0.2	-0.5
2020Q4	42	20	52.1%	1.68	53.53	16.7%	8.0%	0.6	0.1
2020Q3	41	19	54.0%	1.75	51.13	17.2%	8.1%	1.4	0.9
2020Q2	37	17	54.2%	2.03	47.63	16.0%	7.2%	1.6	1.3
2020Q1	37	19	50.2%	2.41	51.49	13.9%	6.8%	0.5	0.4
2019Q4	37	18	52.1%	2.23	49.57	14.3%	7.3%	1.2	1.1
2019Q3	35	17	51.6%	2.30	47.64	14.5%	7.5%	0.8	0.8
2019Q2	38	17	56.0%	1.95	46.19	14.9%	7.4%	0.1	0.0
2019Q1	36	17	52.3%	1.59	48.71	14.7%	8.1%	0.5	0.5
2018Q4	30	16	44.7%	1.60	46.89	14.9%	8.7%	1.3	1.0
2018Q3	28	16	43.8%	1.58	45.17	16.1%	9.4%	0.6	-1.7
2018Q2	26	15	42.1%	1.80	43.70	16.9%	10.0%	0.7	0.7
2018Q1	25	17	33.9%	2.23	47.66	15.3%	10.1%	0.7	0.6
2017Q4	26	16	37.8%	2.03	46.43	15.8%	9.9%	0.6	0.5
2017Q3	25	16	38.9%	1.98	44.40	16.0%	9.9%	0.3	0.3
2017Q2	25	15	38.9%	1.96	42.84	16.4%	9.7%	1.2	0.3
2017Q1	24	16	33.3%	2.38	46.02	13.6%	8.8%	0.3	0.2
2016Q4	25	16	37.0%	2.15	44.44	–	–	1.1	1.1
2016Q3	24	15	36.6%	2.12	42.57	–	–	1.1	1.1